Skip to main content
. 2020 Mar 23;63(1):e34. doi: 10.1192/j.eurpsy.2020.30

Table 4.

Categorical and continuous moderator analyses.

Categorical moderator k ES—r 95% CI z p Q bet, df (p) I2
FTD measure a 14 −0.23 [−0.33, −0.12] −3.99 <0.001 1.90, 1 (0.168) 75.77
 Clinician-rated 9 −0.28 [−0.40, −0.14] −3.97 <0.001 83.73
 Behaviorally based 5 −0.13 [−0.31, 0.07] −1.31 0.192 0.00
Social function measure b 17 −0.21 [−0.30, −0.12] −4.34 <0.001 1.15, 2 (0.563) 72.63
 Self-report 3 −0.25 [−0.46, −0.02] −2.10 0.035 87.47
 Clinician-rated 10 −0.21 [−0.33, −0.08] −3.27 0.001 75.20
 Performance-based 4 −0.20 [−0.38, −0.01] −1.98 0.048 40.67
Study quality 13 −0.23 [−0.33, −0.12] −3.88 <0.001 3.35, 1 (0.067) 77.25
 High 6 −0.28 [−0.44, −0.11] −3.16 0.002 76.44
 Moderate 7 −0.19 [−0.33, −0.04] −2.40 0.016 78.72
Continuous moderator k B R 2 SE 95% CI z p I2 c
%Female 12 −0.21 0.03 0.72 [−1.62, 1.20] −0.29 0.77 78.03
Age 11 0.01 0.00 0.09 [−0.01, 0.03] 0.84 0.40 80.02
Total symptoms 7 −0.01 0.00 0.01 [−0.03, 0.02] −0.34 0.74 70.84
Positive symptoms 9 −0.26 0.00 0.27 [−0.79, 0.27] −0.95 0.34 82.42
Negative symptoms 9 0.07 0.00 0.18 [−0.28, 0.42] 0.42 0.68 82.42

The p-value of Q bet indicates whether the subgroups are significantly different.

Abbreviations: B, regression coefficient; CI, confidence interval; ES, r effect size statistic; I2, extent of between-study variability; k, number of studies used in the calculation of the mean effect size; p, two-tailed p-value associated with the test of statistical significance; Q bet, variance between subgroups; R2, R2 analogue; SE, standard error, z, test for statistical significance of the mean effect size.

a

For this analysis, one study [98] contributed effect sizes to both clinician-rated and behaviorally-based subgroups.

b

For this analysis three studies contributed multiple effect sizes.

c

The I 2 value might be larger than that of the overall main analyses because not all of the studies were included in the moderator analyses.